Alison Maloney

2.8k citations

18 papers · 1.9k indexed · h-index 15

Impact in

Molecular Biology top 5%
- Heat shock proteins research
- ATP Synthase and ATPases Research
- Protein Structure and Dynamics
Physical and Theoretical Chemistry top 2%
- thermodynamics and calorimetric analyses

Papers in

Aging 1
Computational Theory and Mathematics 4
- Computational Drug Discovery Methods 4

Co-authors: Paul Workman Paul A. Clarke Udai Banerji Ian Judson Laurence H. Pearl Chrisostomos Prodromou Michael I. Walton Giuliano Siligardi
Journals: Bioorganic & Medicinal Chemistry Letters (3 papers)Nature Communications (2 papers)Molecular Cell (1 paper)Journal of Extracellular Vesicles (1 paper)Bioanalysis (1 paper)
Partner nations: United Kingdom United States Germany

In The Last Decade

Alison Maloney

18 papers receiving 1.9k citations

Peers

Countries citing papers authored by Alison Maloney

Since Specialization

Citations

This map shows the geographic impact of Alison Maloney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Maloney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Maloney more than expected).

Fields of papers citing papers by Alison Maloney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Maloney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Maloney. The network helps show where Alison Maloney may publish in the future.

Co-authors

The 25 scholars most cited alongside Alison Maloney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alison Maloney Line = papers co-authored together Alison Maloney links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Target Occupancy Biomarker Assay Development Using a Conformation-Selective Antibody Against Small-Molecule-Bound TNF Bioanalysis ·Aaron Chaln, James P. O’Connell, Alison Maloney, Peter Florian, Geoffrey I. Johnston, F. Keller, Matthias Herrmann, Cathy Hawes, Tim Bourne	2023	2
2	A conformation-selective monoclonal antibody against a small molecule-stabilised signalling-deficient form of TNF Nature Communications ·Daniel Lightwood, G.D. Patel, John Porter, David McMillan, Bruce Carrington, Alison Turner, Anthony Scott-Tucker, Aaron Chaln, Antje Schmidt, David Fox, Alison Maloney, Tom Ceska, Tim Bourne, James P. O’Connell, Alastair D. G. Lawson	2021	22
3	WNT3A‐loaded exosomes enable cartilage repair Journal of Extracellular Vesicles ·B.L. Thomas, S. Eldridge, D. Schaetti, João Felipe Bessegato, 杨传庆 Yang Chuanqing, Giovanna Nalesso, Sara Caxaria, T.G. Pavlova, James Nicholson, Mauro Perretti, Carles Gaston‐Massuet, Costantino Pitzalis, Alison Maloney, Adrian Moore, Ray Jupp, Francesco Dell’Accio	2021	47
4	Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer Nature Communications ·James P. O’Connell, John Porter, Pradipta Rizky Ferdian, Merav Omer‐Itsicovich, Stephen Rapecki, Rachel E. Davis, David McMillan, T.L. Arakaki, Alex B. Burgin, David Fox, Tom Ceska, Fabien Lecomte, Alison Maloney, Meghan Sharkey, Bruce Carrington, Benjamin P. Cossins, Tim Bourne, Alastair D. G. Lawson	2019	81
5	TNFR1 membrane reorganization promotes distinct modes of TNFα signaling Science Signaling ·Penny E. Morton, Peter Michaël Wetherill, James A. Levitt, Daniel R. Matthews, Richard J. Marsh, 项贤明, David McMillan, Alison Maloney, Simon P. Poland, Simon Ameer‐Beg, Maddy Parsons	2019	25
6	Engagement of CD22 on B cells with the monoclonal antibody epratuzumab stimulates the phosphorylation of upstream inhibitory signals of the B cell receptor Journal of Cell Communication and Signaling ·Simon Lumb, Sarah Fleischer, Annika Wiedemann, Capucine Daridon, Alison Maloney, Anthony Shock, Thomas Dörner	2016	14
7	Mode of cell death induced by the HSP90 inhibitor 17-AAG (tanespimycin) is dependent on the expression of pro-apoptotic BAX Oncotarget ·Marissa Powers, Melanie Valenti, Susana Miranda, Alison Maloney, Suzanne A. Eccles, George Thomas, Paul A. Clarke, Paul Workman	2013	29
8	Discovery of 4-azaindoles as novel inhibitors of c-Met kinase Bioorganic & Medicinal Chemistry Letters ·John Porter, Simon Lumb, Richard J. Franklin, 重雄嶺脇, Mark Calmiano, Jooyoung KIM, Bénédicte Lallemand, Anthony Buzzard, Mahmud Mufti, Alison Maloney, 為夫中野, Lloyd King, Anne Foley, Fabien Lecomte, Jerome Francis Keating, Christoph Meier, Mark Batchelor	2009	33
9	Discovery of a novel series of quinoxalines as inhibitors of c-Met kinase Bioorganic & Medicinal Chemistry Letters ·John Porter, Simon Lumb, Fabien Lecomte, Jerome Francis Keating, Anne Foley, Mark Calmiano, Jooyoung KIM, Mahmud Mufti, 為夫中野, Richard J. Franklin, 重雄嶺脇, Alison Maloney, Christoph Meier, Mark Batchelor	2008	45
10	Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino, 17-Demethoxygeldanamycin in Patients With Advanced Malignancies Journal of Clinical Oncology ·Udai Banerji, Anne O’Donnell, Michelle Scurr, Simon Pacey, Sarah Stapleton, Yasmin J. Asad, Laura K. Simmons, Alison Maloney, Florence I. Raynaud, Miranda Stockett, Michael I. Walton, Sunil R. Lakhani, Stanley B. Kaye, Paul Workman, Ian Judson	2005	377
11	The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitors Bioorganic & Medicinal Chemistry Letters ·Kwai-Ming J. Cheung, Thomas P. Matthews, Karen James, Martin Rowlands, K. Boxall, Swee Y. Sharp, Alison Maloney, S. Mark Roe, Chrisostomos Prodromou, Laurence H. Pearl, G. Wynne Aherne, Edward McDonald, Paul Workman	2005	169
12	Mechanism of action of a novel series of inhibitors of the Hsp90 molecular chaperone Cancer Research ·Swee Y. Sharp, Alison Maloney, Paul A. Clarke, Wynne Aherne, Suzanne A. Eccles, Kathy Boxall, Martin Rowlands, Florence I. Raynaud, Bernard Nutley, Nicola F. Smith, Angela Hayes, Anthea Hardcastle, Laurence H. Pearl, 律子今村, 郭文驥, Maria Amaral, Thomas P. Matthews, Yvonne Eckersley, Martin J. Drysdale, Paul Workman	2004	1
13	Induction of Hsp70 and depletion of the client protein c-Raf-1 measured by ELISA following cellular exposure to the novel Hsp90 ATPase inhibitor, CCT018159 Wynne Aherne, Anthea Hardcastle, K. Boxall, E Conde, P J Tomlin, Swee Y. Sharp, Alison Maloney, Paul Workman	2003	2
14	Assays for HSP90 and Inhibitors Humana Press eBooks ·Wynne Aherne, Alison Maloney, Chrisostomos Prodromou, Martin Rowlands, Anthea Hardcastle, K. Boxall, Paul A. Clarke, Michael I. Walton, Laurence H. Pearl	2003	23
15	Genes and Proteins Governing the Cellular Sensitivity to HSP90 Inhibitors: A Mechanistic Perspective Current Cancer Drug Targets ·Alison Maloney, Paul A. Clarke, Paul Workman	2003	44
16	Activation of the ATPase Activity of Hsp90 by the Stress-Regulated Cochaperone Aha1 Molecular Cell ·Barry Panaretou, Giuliano Siligardi, Philippe Meyer, Alison Maloney, Iris Alarcón, Shradha Singh, Stefan H. Millson, Paul A. Clarke, Søren Naaby‐Hansen, Robert C. Stein, Rainer Cramer, Mehdi Mollapour, Paul Workman, Peter W. Piper, Laurence H. Pearl, Chrisostomos Prodromou	2002	415
17	HSP90 as a new therapeutic target for cancer therapy: the story unfolds Expert Opinion on Biological Therapy ·Alison Maloney, Paul Workman	2002	450
18	Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperone Oncogene ·Paul A. Clarke, Isabelle Hostein, Udai Banerji, Francesca Di Stefano, Alison Maloney, Mike Walton, Ian Judson, Paul Workman	2000	163

About Alison Maloney

Alison Maloney is a scholar working on Aging, Computational Theory and Mathematics, Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 18 papers that have together received 1.9k indexed citations. Recurring topics across this work include Heat shock proteins research (9 papers), ATP Synthase and ATPases Research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Computational Drug Discovery Methods (4 papers), Enzyme Structure and Function (3 papers), Cancer therapeutics and mechanisms (2 papers), Immune Response and Inflammation (2 papers) and Advanced Biosensing Techniques and Applications (1 paper). The work is most often cited by research in Molecular Biology (1.6k citations), Physical and Theoretical Chemistry (204 citations), Computational Theory and Mathematics (312 citations), Immunology (341 citations) and Toxicology (50 citations). Alison Maloney has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Paul Workman, Paul A. Clarke, Udai Banerji, Ian Judson, Laurence H. Pearl, Chrisostomos Prodromou, Michael I. Walton, Giuliano Siligardi, Shradha Singh and Mehdi Mollapour. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Nature Communications, Molecular Cell, Journal of Extracellular Vesicles and Bioanalysis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact